Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Pinto Joshua
Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Ho Maykin
Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Piacquad David
Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Halawa Alaa
Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Fust Matthew K
Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Burow Kristina
Neumora Therapeutics | 8-K: Current report
Neumora Therapeutics | 10-Q: Quarterly report
Neumora Therapeutics | 8-K: Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
Neumora Therapeutics | DEF 14A: Definitive information statements
Neumora Therapeutics | DEFA14A: Others
Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Aurora Daljit Singh
Neumora Therapeutics | 8-K: Current report
Neumora Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Neumora Therapeutics | 10-K: Annual report
Neumora Therapeutics | 8-K: Neumora Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Pinto Joshua
Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BERNS PAUL L
Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Aurora Daljit Singh
Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Suh Carol Y.
No Data